Survey header PREMIER project
Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Stakeholder needs and requirements regarding the environmental risk assessment of pharmaceuticals

Welcome to this online survey, which maps stakeholder needs on the topic of Pharmaceuticals in the Environment (PIE)!

This survey is carried out in the context of the research project PREMIER (Prioritisation and Risk Evaluation of Medicines in the EnviRonment), an Innovative Medicines Initiative (IMI) project, funded by the European Commission and members of the European Federation of Pharmaceutical Industry Association (EFPIA). PREMIER consists of universities, research institutes, the European Medicines Agency, 10 EFPIA companies, and small-to-medium-enterprises. For more information, please refer to

Why this survey?

PREMIER strives to ensure that stakeholders requirements are taken up in its products and outcomes, by means of a transparent and stakeholder-driven strategy. This survey is part of PREMIER's activities to understand:

  1. stakeholder needs regarding data and data tools in the area of PIE, and
  2. stakeholder interest in (non-regulatory) guidance on the topic.

On the basis this understanding, and in view of other factors such as practical constraints, the consortium will strive to include aspects and features that address these needs in the PREMIER outputs, and will select the most relevant topics for guidance to be developed.

What are the PREMIER outputs relevant to stakeholders?

The two key data products to be developed in PREMIER are:

  • a transparent, publicly and easily accessible database on the occurrence, fate and effects of active pharmaceutical ingredients (APIs) in aquatic and terrestrial systems, also including data on API properties and pharmacology
  • a digital assessment system (DAS), which integrates decision trees, exposure and effect tools, and the above-mentioned database into an information and assessment system on APIs for use by diverse stakeholder groups

In addition, PREMIER will produce (non-regulatory) guidances on topics related to PIE. These guidances can cover a number of possible topics, such as the approaches to quality-assess data, the state-of-play regarding Modes of Action, or the estimation of mixture effects.  

What does this survey do?

The survey aims to map stakeholder needs related to these outputs, by asking you questions regarding:

  1. your data needs
  2. your needs regarding the functionality of data tools
  3. your interest in non-regulatory, scientific and technical guidance related to PIE.

If your work deals in some regard with pharmaceuticals in the environment, we would appreciate you taking some time (approx. 20-30 minutes) to let us know your organisation’s data and guidance needs. This way we ensure that PREMIER’s project outputs are as relevant as possible for the stakeholders that will use them in the future!!

And if before filling in the survey you would like to get an overview of the questions, you can download the questionnaire here.

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875508. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA